The ECV-304 cell-line: should it be used?
Hallevi
H
H
Hazan-Hallevi
I
I
Paran
E
E
D001562:Benzimidazoles / Q000494:pharmacology*; D001713:Biphenyl Compounds; D002545:Brain Ischemia / Q000150:complications*; D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D004176:Dipyridamole / Q000494:pharmacology*; D042783:Endothelial Cells; D006801:Humans; D009504:Neutrophils / Q000187:drug effects*; D020521:Stroke / Q000209:etiology / Q000503:physiopathology*; D013777:Tetrazoles / Q000494:pharmacology*
D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D004176:Dipyridamole; C081643:candesartan